Skip to main content

Table 2 Clinical and Laboratory data for the diabetic subjects during treatment period by Group

From: Family physician and endocrinologist coordination as the basis for diabetes care in clinical practice

 

Baseline

6

12

18

24

30 months

BMI (Kg.m-2)

      

- Group A

28 (25–31)

28 (25–32)

28 (25–32)

28 (25–32)

28 (26–32)

28 (25–32)

- Group B

29 (27–34)

30 (27–32)&

30 (27–33)&

30 (27–32)&

30 (28–36)&

30 (27–35)&

Waist Circumference(cm)

      

- Group A

      

   Men

103 (96–109)

104 (98–109)

102 (97–108)

102 (92–109)

103 (97–109)

103 (97–112)

   Women

100 (88–114)

96 (87–113)

95 (86–110)

98 (81–113)

99 (81–114)

98 (80–115)

-Group B

      

   Men

103 (99–113)

106 (98–115)

106 (98–113)&

103 (99–114)

103 (98–111)

104 (95–118)

   Women

100 (89–114)

104 (84–118)&

110 (83–128)&

107 (82–125)&

101 (78–127)

99 (79–126)

SBP mm Hg

      

- Group A

140 (135–155)

137 (130–144)

135 (125–144)*

135 (125–145)*

135 (125–144)*

130 (125–135)**

- Group B

145 (132–160)

138 (128–150)*

135 (127–150)*

132 (125–144)**

135 (125–145)**

135 (121–147)*

DBP mm Hg

      

- Group A

80 (75–87)

76 (70–80)*

75 (70–80)*

78 (70–80)

78 (70–80)

76 (71–80)*

- Group B

85 (76–90)

79 (70–84) *

78 (71–80)*

77 (70–79)*

77 (69–78)*

78 (68–79)*

HbA1c (%)

      

- Group A

7.2 (6.5–8.5)

7.0 (6.6–7.9)

7.0 (6.6–7.8)

6.9 (6.4–7.8)

7.1 (6.4–7.9)

7.3 (6.5–7.9)

- Group B

7.5 (6.5–9.2)

7.3 (6.3–8.2)

7.4 (6.4–8.0)

7.0 (6.3–8.2)*

7.3 (6.4–8.0)

7.1(6.4–8.3)*

ACR (mg/g)

      

- Group A

22 (8–145)

20 (8–99)

22 (9–66)

15 (9–76)

19 (8–86)

27 (9–97)

- Group B

25 (7–128)

29 (10–137)

25 (8–135)

25 (8–141)

20 (11–105)

25 (9–158)

Total Cholesterol (mg/dl)

      

- Group A

181 (158–208)

165 (151–182)*

165 (150–183)*

155 (135–175)*

154 (129–166)*

148 (135–163)**

- Group B

189 (164–217)

167 (151–200)*

170 (147–185)*

159 (141–178)**

158 (132–182)**

160 (143–185) **

HDL-Cholesterol (mg/dl)

      

-Group A

      

   Men

46 (41–55)

46 (43–56)

50 (43–57)

50 (43–56)

46 (40–54)

48 (40–55)

   Women

55 (48–65)

59 (51–71)

58 (49–65)

64 (50–66)

63 (56–68)

56 (54–64)

-Group B

      

   Men

49 (39–54)

49 (42–55)

50 (44–53)

50 (43–54)

50 (47–55)

50 (45–55)

   Women

50 (42–60)

53 (45–64)

45 (43–58)

48 (42–58)

48 (37–55)

52 (43–57)

LDL-Cholesterol (mg/dl)

      

- Group A

104 (87–128)

93 (83–107)

88 (75–104)*

77 (66–95)**

75 (64–94)**

78 (69–86)**

- Group B

107 (87–136)

96 (78–112)*

91 (77–109)*

82 (72–99)**

80 (64–98)**

81 (70–97) **

Triglycerides (mg/dl)

      

- Group A

102 (85–145)

98 (74–149)

112 (77–139)

108 (71–138)

100 (80–141)

97 (75–137)

- Group B

119 (86–160)

105 (87–160)

109 (80–160)

116 (79–158)

117 (79–152)

105 (79–150)

  1. Group A, diabetic patients treated by endocrinology service. Group B, diabetic patients treated by coordinated team, FP and endocrinologist, at primary care site. Data expressed as median (Q1–Q3).
  2. BMI, body mass index. SBP, Systolic Blood Pressure. DBP, Diastolic Blood Pressure. ACR, albumine-to-creatinine ratio.
  3. *p < 0.05, ** p < 0.01, denote differences in relation to baseline values. &p < 0.05 denote differences between Group A vs. Group B.